Zoe Karli

Zoe Bedford Karli is the President of Greyledge Technologies, a clinical biotech company specializing in regenerative medicine and autologous cell therapeutics. She joined the executive team in 2019 and has been instrumental in expanding the company's operations and strategic direction.

Education and Early Career

Zoe graduated from the University of Virginia in 2005, where she was part of the Navy ROTC program. Following her graduation, she served on active duty in the United States Navy until 2007. After her military service, she transitioned into the business sector, gaining significant experience in sales and operations within the medical and biotechnology fields.

Professional Experience

Before her role at Greyledge Technologies, Zoe held various positions in pharmaceutical and medical device sales:

• Novartis (2006-2009): Worked as a Sales Representative, focusing on launching new cardiovascular medications.
• DePuy Spine (2009-2012): Served as a Sales Consultant in operating room medical device sales.
• Rodan + Fields (2013-2017): Owned an online storefront and developed a successful private distributorship for skincare products.

Her diverse background includes expertise in e-commerce, distribution, and direct sales, which she leverages to drive growth at Greyledge Technologies.

Role at Greyledge Technologies

As President, Zoe Bedford Karli oversees the company's strategic initiatives and operational management. Greyledge Technologies focuses on developing innovative biologic preparations for various medical applications, emphasizing quality control and customization tailored to individual patient needs. Under her leadership, the company has positioned itself for scalable expansion within the regenerative medicine sector.123